
Biotechnology investment firm that creates and funds therapeutics companies, including via its BioImpact arm

Merck's corporate venture fund investing in early-stage preclinical therapeutics companies

MRL Ventures, known as MRLV, is the corporate venture arm of Merck & Co, based in Cambridge, Massachusetts. It invests worldwide in early-stage therapeutics companies that are still preclinical.
Scientists and entrepreneurs with differentiated science, in any therapeutic area or modality. It takes no product or technology rights as a condition of investment. It does not invest in medical devices, diagnostic platforms or digital health.
Summary written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about MRL Ventures.
Similar listings buyers compare against this one.

Biotechnology investment firm that creates and funds therapeutics companies, including via its BioImpact arm

Oregon venture capital fund investing early in minority and women-led startups

Grant-making programme that supported science-based startups where technology meets biology

Corporate venture arm of Johnson & Johnson investing in healthcare companies from seed stage onwards

A healthcare company developing medicines and medical devices across oncology, cardiovascular and other specialisms

University of California San Francisco programme giving seed funding and advice to faculty medical device projects

Private equity investor in the Netherlands backing healthcare and technology companies in the Netherlands and Germany

A crypto ecosystem where holders stake a token to earn a share of fees from projects built on it
Everything here links back to the same verified catalogue. Pick your next stop.